Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer

Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer

Abstract Objectives In lung cancer, surgery remains the most curative treatment and limited resection is beneficial for patients with low cardiopulmonary function and low malignancy tumors. However, there are no biomarkers of low malignancy to select candidates for limited resection without compromi...

Full description

Bibliographic Details
Main Authors: Hirofumi Morimoto, Yasuhiro Hida, Nako Maishi, Hiroshi Nishihara, Yutaka Hatanaka, Cong Li, Yoshihiro Matsuno, Toru Nakamura, Satoshi Hirano, Kyoko Hida
Format: Article
Language:English
Published: Wiley 2021-05-01
Series:Thoracic Cancer
Subjects:
angiogenesis
biglycan
endothelial cell
lung cancer
tumor progression
Online Access:https://doi.org/10.1111/1759-7714.13907

Internet

https://doi.org/10.1111/1759-7714.13907

Similar Items